Amit Munshi

Chief Executive Officer, EPIRUS Biopharmaceuticals, Inc.

Companies

Arcutis Biotherapeutics, Inc.Board member Dec 8, 2025 to now¹
Inhibikase Therapeutics, Inc.Board member Oct 23, 2024 to now²
Zura Bio LtdBoard member Mar 21, 2023 to now³
Damora Therapeutics, Inc.Board member Oct 28, 2020 to now⁴
Arena PharmaceuticalsBoard member Feb 14, 2017 to Mar 11, 2022⁵
Arena PharmaceuticalsChief executive officer May 11, 2016 to Mar 11, 2022⁶
Arena PharmaceuticalsPresident May 11, 2016 to Mar 11, 2022⁶
Social Capital Suvretta Holdings Corp. IVBoard member Jun 29, 2021 to Jun 29, 2021⁷
Pulmatrix, Inc.Board member Jun 15, 2017 to Feb 1, 2021⁸

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jun 5, 2026Granted 5,778 shares of Arcutis Biotherapeutics, Inc.¹¹
Feb 21, 2026Returned to company 19,089 shares of Inhibikase Therapeutics, Inc.¹⁰
Dec 4, 2025Granted 2,021 shares of Arcutis Biotherapeutics, Inc.¹³
Feb 21, 2025Granted 57,265 shares of Inhibikase Therapeutics, Inc.¹⁴
Oct 21, 2024Bought 365,000 shares at $1.37 of Inhibikase Therapeutics, Inc.¹⁵
Apr 22, 2024Bought 159,744 shares at $3.13 of Zura Bio Ltd¹⁶
Apr 22, 2024Granted 159,744 shares at $3.13 of Zura Bio Ltd⁹
Jun 5, 2023Bought 117,647 shares at $4.25 of Zura Bio Ltd¹⁷
Mar 11, 2022Other 85,847 shares of Arena Pharmaceuticals¹²
Mar 11, 2022Other 28,800 shares of Arena Pharmaceuticals¹²
Mar 11, 2022Other 250 shares of Arena Pharmaceuticals¹²
Mar 8, 2022Gift 10,500 shares at $98.51 of Arena Pharmaceuticals¹²
Jan 3, 2022Granted 85,847 shares of Arena Pharmaceuticals¹⁸

The numbers on this page point here. Each one links to the record it came from.